SenoRx, Inc. Announces Poster Presentation on Interim Results of the First 100 Patients in its Contura(TM) MLB Registry Study Delivered at American Society for Radiology and Oncology (ASTRO)

IRVINE, Calif., Nov. 5, 2009 (GLOBE NEWSWIRE) -- SenoRx (Nasdaq:SENO) today announced that a poster presentation summarizing clinical findings of the first 100 patients in its Contura(TM) Multi-Lumen Balloon (MLB) registry study was delivered at the Annual Meeting of the American Society for Radiology and Oncology (ASTRO) on November 3, 2009 in Chicago, Illinois.